TELO

Telomir Pharmaceuticals, Inc. Common Stock (TELO)

US
$ 2.55-0.39%

Price Chart

Key Statistics

Market Cap
$ 74.11M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
58.61K
52W High
$ 8.40
52W Low
$ 2.35
Dividend Yield
0.00%
Beta
0.00

Technicals

50-Day MA
3.6266
200-Day MA
4.4863
52 Week High
8.4
52 Week Low
2.354

About TELO

Telomir Pharmaceuticals, Inc., a pre-clinical stage biopharmaceutical company, focuses on developing pharmaceutical products for reversal of oxidative stress, cellular protection, and regulatory mecha.

Employees
N/A
Headquarters
Miami, FL
CEO
Mr. Erez Aminov

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg